DA
Therapeutic Areas
Innoviva Specialty Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| GIAPREZA (angiotensin II) | Vasodilatory shock, septic shock | Marketed |
| NUZOLVENCE (zoliflodacin) | Uncomplicated urogenital gonorrhea | Marketed |
| XACDURO (sulbactam-durlobactam) | Hospital-acquired bacterial pneumonia (HABP/VABP) caused by Acinetobacter | Marketed |
| XERAVA (eravacycline) | Complicated intra-abdominal infections (cIAI) | Marketed |
| ZEVTERA (ceftobiprole medocaril) | Community-acquired bacterial pneumonia (CABP) and Staphylococcus aureus bacteremia (SAB) | Marketed |
| Zoliflodacin (ZOLI) | Uncomplicated gonorrhea infection | Phase 3 |